시장보고서

상품코드

1565660

경구 항바이러스제 시장 : 유형별, 투여 경로별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Oral Antiviral Market, By Type, By Route of Administration, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 09월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 316 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

경구 항바이러스제 시장 규모는 2023년에 379억 432만 달러에 달하며, 2024-2032년 CAGR 2.90%로 확대

경구 항바이러스제 시장 - 시장 역학

바이러스성 질환의 유병률 증가가 경구 항바이러스제 시장의 성장을 촉진

바이러스성 질환의 유병률 증가는 경구 항바이러스제 시장의 성장을 크게 견인하고 있습니다. 세계보건기구(WHO)에 따르면 인플루엔자와 COVID-19는 여전히 전 세계 보건의 큰 관심사로 매년 수백만 명이 감염되고 있습니다. 미국 질병통제예방센터(CDC)는 COVID-19 팬데믹 기간 중 항바이러스제 처방이 급증했다고 보고하며, 광범위한 감염병 관리에서 경구 항바이러스제의 중요한 역할을 강조하고 있습니다. 예를 들어 COVID-19 경구 항바이러스제인 팍스로비드는 출시 첫 해에 50만 명 이상의 환자에게 처방되었습니다. 또한 단순 포진과 같은 만성 바이러스성 질환 증가로 인해 효과적인 경구용 치료제에 대한 수요가 증가하고 있습니다. 전 세계에서 바이러스성 질환에 대한 대응이 강화되는 가운데, 항바이러스제 시장 개척이 진행되고 있으며, 이러한 의약품에 대한 접근성이 확대되는 것은 시장 성장을 가속하는 중요한 요인으로 작용하고 있습니다.

경구 항바이러스제 시장 - 주요 인사이트

당사의 리서치 애널리스트들의 분석에 따르면 세계 시장은 예측 기간(2024-2032) 동안 매년 약 2.90%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

시장 세분화에서 뉴클레오시드 유사체는 2023년에 가장 높은 시장 점유율을 보였습니다.

투여 경로별로는 2023년 정제가 주요 유형으로 부상할 것으로 예상됩니다.

용도별로는 2023년 COVID-19가 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

경구 항바이러스제 시장 - 세분화 분석 :

세계 경구 항바이러스제 시장은 유형, 투여 경로, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 뉴클레오시드 유사체, 프로테아제 억제제, 뉴라미니다제 억제제, 중합효소 억제제, 폴리머라제 억제제 등 네 가지 범주로 나뉩니다. 뉴클레오시드 유사체는 다양한 바이러스 감염에 대한 광범위한 효과로 인해 시장을 선도하고 있습니다. 프로테아제 억제제는 특정 바이러스를 표적으로 삼아 작용합니다. 뉴라미니다제 억제제는 인플루엔자 치료에 중요하며, 중합효소 억제제는 중요하지만 덜 사용됩니다.

시장은 투여 경로에 따라 정제, 캡슐, 경구 현탁액 등 세 가지 범주로 나뉩니다. 정제는 편리함과 복용량의 정확성으로 인해 가장 인기 있는 투여 경로입니다. 캡슐은 그 뒤를 이어 다른 투여 형태이지만 유사한 이점을 제공합니다. 경구 현탁액의 사용 빈도는 낮지만, 정제나 캡슐을 삼키기 어려운 환자에게는 매우 유용합니다.

경구 항바이러스제 시장 - 지역적 인사이트

경구 항바이러스제 시장은 지역별로 차이가 있으며, 북미가 첨단화된 의료 시스템과 높은 약물 채택률로 선두를 달리고 있습니다. 미국에서는 COVID-19 대유행 당시 FDA가 팍스로비드와 같은 경구 항바이러스제를 신속하게 승인하여 첫 해에 1,000만 회 이상 투여되어 널리 사용되었습니다. 영국과 독일과 같은 국가들은 종합적인 항바이러스 치료 프로그램을 시행하여 시장 수요를 크게 증가시켰습니다. 유럽의약품청(EMA)은 새로운 항바이러스제의 신속한 승인을 통해 이러한 성장을 지원하고 있습니다. 아시아태평양에서는 바이러스 감염률 증가와 의료 투자 증가로 인해 일본과 인도와 같은 국가들이 급속한 시장 확대를 경험하고 있습니다. 예를 들어 일본 후생성은 독감 유행에 대응하기 위해 경구 항바이러스제 사용을 장려하고 있습니다. 라틴아메리카와 중동 및 아프리카도 의료 인프라 증가와 항바이러스 치료에 대한 인식이 높아지면서 성장 시장으로 부상하고 있습니다.

경구 항바이러스제 시장 - 경쟁 구도:

경구 항바이러스제 시장은 경쟁이 치열한 시장이며, 주요 기업은 시장 지위를 유지하기 위한 전략적 노력을 적극적으로 펼치고 있습니다. 선도기업인 화이자는 COVID-19 치료제 팍스로비드를 출시하고 2022년 빌&멜린다 게이츠 재단과 파트너십을 맺고 저소득 국가의 항바이러스 치료 접근성을 확대하기 위해 노력하고 있습니다. 머크는 COVID-19 치료제 모르누피라비르로 주목을 받았으며, 2021년에는 리지백 바이오테라퓨틱스(Ridgeback Biotherapeutics)와 파트너십을 맺고 개발 및 유통에 박차를 가했습니다. 베클루리(렘데시비르)로 잘 알려진 길리어드 사이언스는 항바이러스 포트폴리오를 지속적으로 혁신하고 확장하고 있습니다. 또한 로슈 홀딩스는 2023년 항바이러스제 TIB 몰비올(TIB Morbiol)을 인수해 바이러스 진단 및 치료 분야에서 입지를 강화하고 있습니다. 이들 기업은 파트너십, 인수 및 제휴를 통해 항바이러스제 공급을 강화하고 효과적인 경구용 항바이러스 요법에 대한 세계 수요 증가에 대응하고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 경구 항바이러스제 업계

경쟁 대시보드
기업 개요
- AbbVie Inc.
- Amgen Inc.
- Aurobindo Pharma Limited
- BioCryst Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- Cipla Limited
- Dr. Reddy's Laboratories Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Johnson &Johnson Services, Inc.
- Merck &Co., Inc.
- Mylan NV(part of Viatris Inc.)
- Novartis International AG
- Pfizer Inc.
- Roche Holding AG
- Teva Pharmaceutical Industries Ltd.
- Others

제13장 애널리스트의 전방위 전망

KSA 24.10.22

REPORT HIGHLIGHT

Oral Antiviral Market size was valued at USD 37,904.32 Million in 2023, expanding at a CAGR of 2.90% from 2024 to 2032.

The Oral Antiviral Market focuses on medications taken by mouth to treat viral infections, providing an accessible and convenient option for patients. The market is experiencing growth due to the increasing prevalence of viral diseases such as influenza, COVID-19, and herpes simplex. For example, the global market saw a notable rise in oral antiviral treatments with the approval of Paxlovid in 2021, which has been widely utilized for COVID-19 management. However, challenges such as high drug costs and concerns about long-term resistance can impede market growth. Opportunities lie in the development of next-generation oral antivirals with broader efficacy and lower resistance profiles. Additionally, the rising emphasis on personalized medicine and the expansion of healthcare access in emerging markets are contributing to the growth of oral antiviral therapies. The growing number of antiviral drugs in the pipeline and increasing investment in research and development further underscore the market's potential.

Oral Antiviral Market- Market Dynamics

Increasing Prevalence of Viral Diseases Boosts Growth in Oral Antiviral Market

The increasing prevalence of viral diseases is significantly driving the growth of the Oral Antiviral Market. According to the World Health Organization (WHO), influenza and COVID-19 remain major global health concerns, with millions affected annually. The U.S. Centers for Disease Control and Prevention (CDC) reported a surge in antiviral prescriptions during the COVID-19 pandemic, highlighting the critical role of oral antivirals in managing widespread infections. For instance, Paxlovid, an oral antiviral for COVID-19, was prescribed to over 500,000 patients in its first year of availability. Additionally, the rise in chronic viral conditions, such as herpes simplex, has increased the demand for effective oral treatments. As the global focus on combating viral diseases intensifies, advancements in antiviral drug development and expanding access to these medications are crucial factors driving market growth.

Oral Antiviral Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.90% over the forecast period (2024-2032)

Based on Type segmentation, Nucleoside Analogues were predicted to show maximum market share in the year 2023

Based on Route of Administration segmentation, Tablets was the leading type in 2023

Based on Application segmentation, COVID-19 was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Oral Antiviral Market- Segmentation Analysis:

The Global Oral Antiviral Market is segmented on the basis of Type, Route of Administration, Application, End-User, and Region.

The market is divided into four categories based on Type: Nucleoside Analogues, Protease Inhibitors, Neuraminidase Inhibitors, and Polymerase Inhibitors. Nucleoside analogues lead the market due to their broad efficacy against various viral infections. Protease inhibitors follow, offering targeted action against specific viruses. Neuraminidase inhibitors are significant for influenza treatment, while polymerase inhibitors are crucial but less commonly used.

The market is divided into three categories based on Route of Administration: Tablets, Capsules, and Oral Suspensions. Tablets are the most popular route of administration due to their convenience and dosage accuracy. Capsules follow closely, offering similar benefits with a different format. Oral suspensions are used less frequently but are valuable for patients who have difficulty swallowing tablets or capsules.

Oral Antiviral Market- Geographical Insights

The Oral Antiviral Market shows distinct regional variations, with North America leading due to advanced healthcare systems and high drug adoption rates. In the U.S., the FDA's rapid approval of oral antivirals like Paxlovid during the COVID-19 pandemic led to widespread use, with over 10 million doses administered in the first year. Europe follows closely, where countries such as the UK and Germany have implemented comprehensive antiviral treatment programs, significantly increasing market demand. The European Medicines Agency (EMA) has supported this growth by fast-tracking approvals for new antiviral drugs. In the Asia-Pacific region, countries like Japan and India are experiencing rapid market expansion due to rising viral infection rates and increased healthcare investments. For instance, Japan's Ministry of Health has promoted the use of oral antivirals in managing influenza outbreaks. Latin America and the Middle East & Africa are also growing markets, driven by increasing healthcare infrastructure and rising awareness of antiviral treatments.

Oral Antiviral Market- Competitive Landscape:

The Oral Antiviral Market is competitive, with major players actively engaging in strategic initiatives to maintain their market positions. Pfizer, a leading player, launched Paxlovid for COVID-19 and partnered with the Bill & Melinda Gates Foundation in 2022 to expand access to antiviral treatments in low-income countries. Merck & Co. has made headlines with its Molnupiravir for COVID-19, and in 2021, it collaborated with Ridgeback Biotherapeutics to accelerate its development and distribution. Gilead Sciences, known for Veklury (remdesivir), has continued to innovate and expand its antiviral portfolio. Additionally, Roche Holdings acquired the antiviral company TIB Molbiol in 2023 to strengthen its position in viral diagnostics and treatments. These companies are leveraging partnerships, acquisitions, and collaborations to enhance their antiviral offerings and address the growing global demand for effective oral antiviral therapies.

Recent Developments:

In November 2021, Pfizer's investigational COVID-19 oral antiviral, PAXLOVID(TM), demonstrated an 89% reduction in hospitalization or death risk in high-risk adults during a Phase 2/3 study. The company plans to submit data to the FDA for Emergency Use Authorization soon.

In October 2021, Merck and Ridgeback Biotherapeutics announced that their investigational oral antiviral, molnupiravir, reduced the risk of hospitalization or death by about 50% in mild to moderate COVID-19 patients. They plan to seek Emergency Use Authorization from the FDA based on these results.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ORAL ANTIVIRAL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.
Amgen Inc.
Aurobindo Pharma Limited
BioCryst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Mylan N.V. (part of Viatris Inc.)
Novartis International AG
Pfizer Inc.
Roche Holding AG
Teva Pharmaceutical Industries Ltd.
Others

GLOBAL ORAL ANTIVIRAL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Nucleoside Analogues
Protease Inhibitors
Neuraminidase Inhibitors
Polymerase Inhibitors

GLOBAL ORAL ANTIVIRAL MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Tablets
Capsules
Oral Suspensions

GLOBAL ORAL ANTIVIRAL MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

HIV
Hepatitis
Influenza
COVID-19
Herpes

GLOBAL ORAL ANTIVIRAL MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Clinics
Homecare Settings
Pharmacies

GLOBAL ORAL ANTIVIRAL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Oral Antiviral Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Oral Antiviral Market Snippet by Type
- 2.1.2. Oral Antiviral Market Snippet by Route of Administration
- 2.1.3. Oral Antiviral Market Snippet by Application
- 2.1.4. Oral Antiviral Market Snippet by End-User
- 2.1.5. Oral Antiviral Market Snippet by Country
- 2.1.6. Oral Antiviral Market Snippet by Region
2.2. Competitive Insights

3. Oral Antiviral Key Market Trends

3.1. Oral Antiviral Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Oral Antiviral Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Oral Antiviral Market Opportunities
3.4. Oral Antiviral Market Future Trends

4. Oral Antiviral Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Oral Antiviral Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Oral Antiviral Market Landscape

6.1. Oral Antiviral Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Oral Antiviral Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Nucleoside Analogues
- 7.1.3. Protease Inhibitors
- 7.1.4. Neuraminidase Inhibitors
- 7.1.5. Polymerase Inhibitors

8. Oral Antiviral Market - By Route of Administration

8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 8.1.2. Tablets
- 8.1.3. Capsules
- 8.1.4. Oral Suspensions

9. Oral Antiviral Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. HIV
- 9.1.3. Hepatitis
- 9.1.4. Influenza
- 9.1.5. COVID-19
- 9.1.6. Herpes

10. Oral Antiviral Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinics
- 10.1.4. Homecare Settings
- 10.1.5. Pharmacies

11. Oral Antiviral Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Oral Antiviral Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Oral Antiviral Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Oral Antiviral Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Oral Antiviral Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Oral Antiviral Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Oral Antiviral Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. AbbVie Inc.
- 12.2.2. Amgen Inc.
- 12.2.3. Aurobindo Pharma Limited
- 12.2.4. BioCryst Pharmaceuticals, Inc.
- 12.2.5. Bristol-Myers Squibb Company
- 12.2.6. Cipla Limited
- 12.2.7. Dr. Reddy's Laboratories Ltd.
- 12.2.8. Gilead Sciences, Inc.
- 12.2.9. GlaxoSmithKline plc
- 12.2.10. Johnson & Johnson Services, Inc.
- 12.2.11. Merck & Co., Inc.
- 12.2.12. Mylan N.V. (part of Viatris Inc.)
- 12.2.13. Novartis International AG
- 12.2.14. Pfizer Inc.
- 12.2.15. Roche Holding AG
- 12.2.16. Teva Pharmaceutical Industries Ltd.
- 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us